16S rRNA sequencing transformed acne microbiome research by enabling species-level bacterial identification that earlier culture-based methods simply could not achieve. Before this technology became standard, scientists could only grow bacteria in laboratory cultures—a process that left the vast majority of skin microbes invisible because they won’t grow on plates. When 16S sequencing arrived, researchers could finally sequence the genetic fingerprint of every bacterium present in acne lesions and healthy skin, revealing the complete microbial landscape for the first time. This shift from “what we can culture” to “what’s actually there” fundamentally changed how researchers understand acne pathogenesis and why certain microbes matter more than others.
The impact extended far beyond simply counting bacteria. 16S sequencing revealed that the bacterial strains present in acne-prone skin are not all the same—even when the dominant species is identical between acne patients and healthy individuals. Some strains are inflammatory triggers; others are benign. The technology also uncovered hostile interactions between species that explain dysbiosis patterns, showed that lesions have markedly different microbial communities from healthy skin in unexpected ways, and connected psychological stress to microbiome changes through direct sequencing data. This article explores how 16S rRNA sequencing answered questions that culture-based methods couldn’t even ask, and what those answers mean for understanding and potentially treating acne.
Table of Contents
- How 16S rRNA Sequencing Overcame the Limitations of Culture-Based Acne Research
- The V1-V3 Region and Why Sequencing Protocol Matters for Acne Research
- Acne Lesions vs. Healthy Skin: The Microbial Landscape Revealed by 16S Sequencing
- Strain-Level Diversity and the Inflammatory Phenotype of Acne-Associated Bacteria
- Functional Predictions and Understanding Disease Mechanisms Beyond Taxonomy
- Hostile Microbial Interactions and the Dysbiosis Puzzle in Acne
- Emotional Stress, Microbiome Changes, and New Research Directions
- Conclusion
How 16S rRNA Sequencing Overcame the Limitations of Culture-Based Acne Research
The traditional approach to studying acne bacteria was straightforward: take a sample, grow it on a medium, and identify what grows. The problem was that this method identified almost nothing of clinical importance. The vast majority of bacteria in the skin microbiome cannot be cultured under standard laboratory conditions, so researchers were working with a tiny, biased subset of the actual community. When 16S rRNA gene sequencing became available, it provided direct genetic identification of bacteria regardless of whether they could be grown in the lab—a capability that immediately revealed the researchers had been studying the wrong organisms all along.
16S sequencing works by reading a specific region of bacterial DNA that varies between species, allowing researchers to classify organisms precisely without culturing them. This distinction matters profoundly for acne research because it shifted the focus from occasional isolates to the dominant bacteria that actually colonize skin. For example, *Cutibacterium acnes* (formerly *Propionibacterium acnes*) became clearly visible as a keystone organism in acne pathology—something culture-based work had suggested but never proven comprehensively. The species-level identification capability also revealed bacterial diversity that was completely invisible before, showing that even within single species there are multiple strains with different inflammatory properties.
The V1-V3 Region and Why Sequencing Protocol Matters for Acne Research
Not all 16S sequencing methods are equally effective for acne microbiome research. The V1-V3 region of the 16S rRNA gene emerged as the gold standard for skin microbiome studies because it provides the most accurate identification of acne-related bacteria. Critically, primers targeting the V4 region—which became popular in other microbiome studies—fail to adequately recover *Cutibacterium acnes*, the primary organism in acne pathogenesis. This means that well-intentioned research using V4 sequencing could dramatically underestimate or miss entirely the bacterial species most relevant to acne.
This protocol detail illustrates an important limitation in microbiome research: the method chosen at the outset can determine which organisms you will and won’t see. A researcher using V4 sequencing might conclude that the acne microbiome is dominated by *Staphylococcus* or *Corynebacterium* when in fact *Cutibacterium acnes* is present but invisible to their primers. This has real consequences for therapeutic development—targeting bacteria you can see is different from targeting the actual drivers of disease. As acne microbiome research has matured, the field has increasingly standardized on V1-V3 sequencing specifically because it captures the organisms that matter most, but earlier work and studies using other methods require careful interpretation.
Acne Lesions vs. Healthy Skin: The Microbial Landscape Revealed by 16S Sequencing
One of the most striking findings from 16S sequencing is that microbial communities in acne lesions are markedly different from healthy skin in ways that culture-based methods never revealed. Lesions show significantly higher proportions of *Bacteroidota* and *Bacillota* bacteria compared to healthy skin, which is dominated by *Actinobacteria*—a phylum that includes *Cutibacterium acnes*. Within lesions, bacteria like *Staphylococcus*, *Corynebacterium*, and *Peptoniphilus* become much more abundant, while paradoxically, *Cutibacterium acnes* itself is actually more abundant in healthy skin than in lesioned skin. This finding seems counterintuitive at first: if *C. acnes* is the acne bacterium, why is it more abundant in healthy skin? The answer lies in strain diversity and inflammatory potential.
Even though healthy individuals harbor *Cutibacterium acnes*, the strains present differ significantly from those in acne patients. Acne patients show higher diversity of *C. acnes* populations with more ribotypes per individual, and crucially, pro-inflammatory strains (phylotype IA1) are enriched in acne-prone individuals. Type II strains, by contrast, are more common in healthy skin. The presence of a bacterium matters far less than which strain you have and what other organisms are present—a distinction that only genomic sequencing could reveal.
Strain-Level Diversity and the Inflammatory Phenotype of Acne-Associated Bacteria
16S sequencing enabled researchers to move beyond asking “is *Cutibacterium acnes* present?” to asking “which strains of *C. acnes* are present, and are they inflammatory?” This strain-level resolution revealed that *C. acnes* populations in acne patients are not only more abundant at the species level but also more diverse, with acne patients typically harboring multiple distinct ribotypes per individual. The heterogeneity within the species is crucial: some strains carry genes associated with inflammation and biofilm formation, while others are essentially commensals.
The distinction between phylotype IA1 (pro-inflammatory, enriched in acne) and Type II (benign, enriched in healthy skin) demonstrates why sequencing at the strain level matters. Even with the same dominant species, different bacterial populations can produce entirely different clinical outcomes. This understanding opens therapeutic possibilities that didn’t exist before: targeting specific inflammatory strains while preserving beneficial commensals might be more effective than attempting to eliminate *C. acnes* entirely, which may be impossible and potentially counterproductive. The limitation here is that standard 16S sequencing provides strain identification but not functional validation—just because a strain carries inflammatory genes doesn’t guarantee it causes inflammation in every context.
Functional Predictions and Understanding Disease Mechanisms Beyond Taxonomy
16S sequencing produces taxonomic data—a list of which bacteria are present—but it doesn’t directly show what those bacteria are actually doing. To bridge this gap, computational tools like PICRUSt2 predict functional abundance from 16S sequences, enabling inference of microbial metabolic function and pathogenic pathways. Instead of only knowing which bacteria colonize acne-prone skin, researchers can now predict what metabolic capabilities the entire community possesses, which immune-triggering molecules it likely produces, and which biosynthetic pathways are active.
This functional prediction approach has revealed that acne-associated microbiome communities show enriched pathways related to lipid metabolism, biofilm formation, and immunogenic compound production compared to healthy skin communities. However, a critical limitation is that these are predictions based on typical metabolic capabilities of known bacteria—they are not direct measurements. Actual metabolic output depends on environmental conditions, nutrient availability, and competitive interactions that lab models may not capture. A bacterium carrying genes for lipopolysaccharide synthesis doesn’t necessarily produce large quantities in the skin environment, so functional predictions should be interpreted as hypotheses for further testing rather than confirmed mechanisms.
Hostile Microbial Interactions and the Dysbiosis Puzzle in Acne
16S sequencing studies have identified that *Cutibacterium acnes* engages in hostile interactions with *Staphylococcus* and *Malassezia globosa*, microbial antagonisms that help explain the dysbiosis patterns observed in acne lesions. These interactions—where one organism inhibits or suppresses another through production of antimicrobial compounds or competition for resources—appear to drive shifts in community composition that are associated with acne development. When *C. acnes* dominates through hostile interactions that suppress competitors, the resulting community becomes dysbiotic in a way that promotes inflammation and lesion formation.
Understanding these antagonistic relationships reframes the acne microbiome from a simple overgrowth problem to a community ecology problem. The presence of *Staphylococcus* or *Malassezia* in lesions is not coincidental; their abundance may reflect successful defense against *C. acnes* suppression or alternatively, their emergence as secondary colonizers in an inflamed microenvironment. 16S sequencing reveals these patterns but cannot yet answer whether specific antagonism is cause or consequence. Future metagenomic or metabolomic studies may clarify these relationships, but the discovery of hostile interactions itself was only possible because 16S sequencing could simultaneously track multiple species and correlate their fluctuations across many samples.
Emotional Stress, Microbiome Changes, and New Research Directions
Among the more unexpected discoveries from 16S amplicon sequencing is the direct link between emotional states and changes in facial skin microbiome composition. Research published through 2025 has revealed that altered emotional states induce measurable changes in facial microbiome, connecting psychological stress to dysbiosis at the microbial level. This finding would have been impossible to detect through culture-based methods because the changes occur in the composition of unculturable communities and manifest as subtle shifts in relative abundance of multiple species simultaneously.
The stress-microbiome axis in acne opens entirely new therapeutic directions beyond antimicrobial or retinoid treatments. If emotional stress systematically alters microbiome composition toward a dysbiotic state, then interventions addressing stress—whether behavioral, pharmacological, or through other means—might prove therapeutic by restoring microbiome balance rather than by killing bacteria. This represents a genuinely new paradigm that emerged specifically from the capability of 16S sequencing to correlate psychological variables with microbial community changes in large cohorts. The limitation is that correlation does not establish causation or optimal treatment targets; stress-induced microbiome changes might be a marker rather than a driver of acne severity, and the therapeutic utility of targeting this axis remains unclear.
Conclusion
16S rRNA sequencing fundamentally transformed acne microbiome research by making the invisible visible—revealing complete bacterial communities rather than only the organisms that happened to grow in laboratory cultures. The technology enabled species-level identification of previously unknown organisms, revealed that strain diversity matters more than species presence, uncovered hostile microbial interactions that drive dysbiosis, and made possible discoveries like the connection between psychological stress and microbiome composition. Through careful protocol selection (particularly the V1-V3 region), researchers have built a coherent picture of how the skin microbiome differs between acne-prone and healthy individuals. The practical impact of these discoveries is still unfolding.
Understanding that *C. acnes* strains differ in inflammatory potential suggests that targeted bacterial strain elimination might outperform broad-spectrum approaches, though no such therapies exist yet. Recognizing stress-microbiome links opens avenues for investigating whether microbiome-targeted therapies can complement existing acne treatments. As 16S sequencing becomes standard and is increasingly paired with complementary technologies like metagenomics and metabolomics, the acne field will likely shift from asking “what bacteria are present?” to “what are they actually doing, and how do we correct dysbiosis without eliminating beneficial organisms?”.
